Turrini O - Search Results

1

Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience.

Schmidt CM, Turrini O, Parikh P, House MG, Zyromski NJ, Nakeeb A, Howard TJ, Pitt HA, Lillemoe KD. Schmidt CM, et al. Among authors: turrini o. Arch Surg. 2010 Jul;145(7):634-40. doi: 10.1001/archsurg.2010.118. Arch Surg. 2010. PMID: 20644125

2

Very high serum CA 19-9 levels: a contraindication to pancreaticoduodenectomy?

Turrini O, Schmidt CM, Moreno J, Parikh P, Matos JM, House MG, Zyromski NJ, Nakeeb A, Pitt HA, Lillemoe KD. Turrini O, et al. J Gastrointest Surg. 2009 Oct;13(10):1791-7. doi: 10.1007/s11605-009-0916-5. Epub 2009 May 21. J Gastrointest Surg. 2009. PMID: 19459018

3

Pancreatic acinar cell carcinoma: a multi-institutional study.

Matos JM, Schmidt CM, Turrini O, Agaram NP, Niedergethmann M, Saeger HD, Merchant N, Johnson CS, Lillemoe KD, Grützmann R. Matos JM, et al. Among authors: turrini o. J Gastrointest Surg. 2009 Aug;13(8):1495-502. doi: 10.1007/s11605-009-0938-z. Epub 2009 Jun 3. J Gastrointest Surg. 2009. PMID: 19495891

4

Preservation of replaced or accessory right hepatic artery during pancreaticoduodenectomy for adenocarcinoma: impact on margin status and survival.

Turrini O, Wiebke EA, Delpero JR, Viret F, Lillemoe KD, Schmidt CM. Turrini O, et al. J Gastrointest Surg. 2010 Nov;14(11):1813-9. doi: 10.1007/s11605-010-1272-1. Epub 2010 Aug 10. J Gastrointest Surg. 2010. PMID: 20697832

5

Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy.

Turrini O, Waters JA, Schnelldorfer T, Lillemoe KD, Yiannoutsos CT, Farnell MB, Sarr MG, Schmidt CM. Turrini O, et al. HPB (Oxford). 2010 Sep;12(7):447-55. doi: 10.1111/j.1477-2574.2010.00196.x. HPB (Oxford). 2010. PMID: 20815853 Free PMC article.

6

Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation?

Turrini O, Schmidt CM, Pitt HA, Guiramand J, Aguilar-Saavedra JR, Aboudi S, Lillemoe KD, Delpero JR. Turrini O, et al. HPB (Oxford). 2011 Feb;13(2):126-31. doi: 10.1111/j.1477-2574.2010.00256.x. HPB (Oxford). 2011. PMID: 21241430 Free PMC article.

7

Initial experience with hyperthermic intraperitoneal chemotherapy.

Turrini O, Lambaudie E, Faucher M, Viret F, Blache JL, Houvenaeghel G, Delpero JR. Turrini O, et al. Arch Surg. 2012 Oct;147(10):919-23. doi: 10.1001/archsurg.2012.988. Arch Surg. 2012. PMID: 23117830

8

Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.

Bergeat D, Turrini O, Courtin-Tanguy L, Truant S, Darnis B, Delpero JR, Mabrut JY, Regenet N, Sulpice L. Bergeat D, et al. Among authors: turrini o. Langenbecks Arch Surg. 2018 Sep;403(6):701-709. doi: 10.1007/s00423-018-1702-1. Epub 2018 Aug 15. Langenbecks Arch Surg. 2018. PMID: 30112638

9

Postoperative day 1 combination of serum C-reactive protein and drain amylase values predicts risks of clinically relevant pancreatic fistula. The "90-1000" score.

Guilbaud T, Garnier J, Girard E, Ewald J, Risse O, Moutardier V, Chirica M, Birnbaum DJ, Turrini O. Guilbaud T, et al. Among authors: turrini o. Surgery. 2021 Nov;170(5):1508-1516. doi: 10.1016/j.surg.2021.04.033. Epub 2021 Jun 3. Surgery. 2021. PMID: 34092376

10

Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?

Turrini O, Ewald J, Barbier L, Mokart D, Blache JL, Delpero JR. Turrini O, et al. Ann Surg. 2013 Apr;257(4):726-30. doi: 10.1097/SLA.0b013e318269d23c. Ann Surg. 2013. PMID: 22968078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters